{
}
President-elect Donald Trump has appointed Robert F. Kennedy Jr., an environmental lawyer and controversial figure known for his anti-vaccine stance, to lead the Department of Health and Human Services. Kennedy, who previously ran for president as an independent, has pledged to be an "honest public servant" focused on transparency and evidence-based science. Critics, including DNC officials, have condemned the choice, citing Kennedy's history of spreading misinformation and personal controversies.
Executives from various healthcare sectors, including Blue Shield of California, are calling for an end to the pharmacy benefit manager (PBM) model, citing misaligned incentives that inflate drug costs. They advocate for transparent fee structures and direct deals with drug manufacturers to reduce expenses. The Federal Trade Commission has criticized PBMs for anticompetitive practices, urging a realignment of incentives to benefit patients rather than middlemen.
As the election approaches, Vice President Kamala Harris and former President Donald Trump diverge on pharmaceutical policies. Harris aims to expand Medicare's drug price negotiations and has garnered significant industry support, while Trump has shifted to align with industry lobbyists, distancing himself from previous commitments to lower drug prices and eliminate rebates. The pharmaceutical sector faces critical stakes in the upcoming election, with contrasting visions from the two candidates.
PhRMA
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Trump appoints Robert F Kennedy Jr as head of Health and Human Services
04:28 15.11.2024
healthcare leaders call for end to pharmacy benefit manager model
PhRMA
Blue Shield of California Employees Retirement Plan RETIREMENT PLAN
Walgreens Boots Alliance, Inc.
UnitedHealth Group Incorporated
Cigna Corporation
Amazon.com, Inc.
CVS Health Corporation
USA
Rick Gates
Paul Markovich
Laura Jensen
Lori Reilly
Show more
08:54 23.10.2024
trump and harris diverge on pharmaceutical policies ahead of election
12:19 15.10.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Government Economic Policies
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Venture Capital Investments
Fintech Startups
CEO Changes
Inflation and Monetary Impact
Finance Mergers & Acquisitions
Central Bank Actions
AI Innovations
Emerging Startups
Workplace Trends
Energy Sector Developments
Countries:
Companies:
Apple Inc.
Google Inc.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
NIO Inc.
Nikkei 225
Delhivery Limited
Ecom Express Ltd.
Nintendo Co., Ltd.
EFG Hermes Egypt
Microsoft Corporation
Eurasia Groupe SA
British International Investment plc
XPeng Inc.
Li Auto Inc.
Morgan Stanley
Taiwan Semiconductor Manufacturing Company Limited
VFS Global AG
LARGAN Precision Co.,Ltd
S&P/ASX 200
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
South Korean Won
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
Egyptian Pound
People: